plasmin/stromelysin-1 cascade enhances tumor cell invasion. J biol chem 274: 13066–13076. 47. Monea S, Lehti K, Keski-Oja J, Mignatti P (2002) Plasmin activates pro-matrix metalloproteinase-2 with a membrane-type 1 matrix metalloproteinase-de- pendent mechanism. J Cell Physiol 192: 160–170. 48. Hollas W, Blasi F, Boyd D (1991) Role of the urokinase receptor in facilitating extracellular matrix invasion by cultured colon cancer. Cancer Res 51: 3690– 3695. 49. Achbarou A, Kaiser S, Tremblay G, Ste-Marie LG, Brodt P, et al. (1994) Urokinase overproduction results in increased skeletal metastasis by prostate cancer cells in vivo. Cancer Res 54: 2372–2377. 50. Sullivan R, Graham CH (2007) Hypoxia-driven selection of the metastatic phenotype. Cancer Metastasis Rev 26: 319–331. 51. Skelly MM, Troy A, Duffy MJ, Mulcahy HE, Duggan C, et al. (1997) Urokinase-type plasminogen activator in colorectal cancer: relationship with clinicopathological features and patient outcome. Clin Cancer Res 3: 1837– 1840. 52. Baker EA, Bergin FG, Leaper DJ (2000) Plasminogen activator system, vascular endothelial growth factor, and colorectal cancer progression. Molecular pathology : MP 53: 307–312. 53. Gettemans J, Van Impe K, Delanote V, Hubert T, Vandekerckhove J, et al. (2005) Nuclear actin-binding proteins as modulators of gene transcription. Traffic 6: 847–857. 54. Archer SK, Claudianos C, Campbell HD (2005) Evolution of the gelsolin family of actin-binding proteins as novel transcriptional coactivators. Bioessays 27: 388– 396. 55. Nishimura K, Ting HJ, Harada Y, Tokizane T, Nonomura N, et al. (2003) Modulation of androgen receptor transactivation by gelsolin: A newly identified androgen receptor coregulator. Cancer Res 63: 4888–4894. Gelsolin Induces Cancer Invasion via uPA Cascade 56. Ambrosino C, Tarallo R, Bamundo A, Cuomo D, Franci G, et al. (2010) Identification of a hormone-regulated dynamic nuclear actin network associated with estrogen receptor alpha in human breast cancer cell nuclei. Mol Cell Proteomics 9: 1352–1367. 57. De Corte V, Van Impe K, Bruyneel E, Boucherie C, Mareel M, et al. (2004) Increased importin-beta-dependent nuclear import of the actin modulating protein CapG promotes cell invasion. J Cell Sci 117: 5283–5292. 58. Herszenyi L, Farinati F, Cardin R, Istvan G, Molnar LD, et al. (2008) Tumor marker utility and prognostic relevance of cathepsin B, cathepsin L, urokinase- type plasminogen activator, plasminogen activator inhibitor type-1, CEA and CA 19–9 in colorectal cancer. BMC Cancer 8: 194. 59. Shariat SF, Roehrborn CG, McConnell JD, Park S, Alam N, et al. (2007) Association of the circulating levels of the urokinase system of plasminogen activation with the presence of prostate cancer and invasion, progression, and metastasis. J Clin Oncol 25: 349–355. 60. Kalwat MA, Wiseman DA, Luo W, Wang Z, Thurmond DC (2012) Gelsolin associates with the N terminus of syntaxin 4 to regulate insulin granule exocytosis. Mol Endocrinol 26: 128–141. 61. Clark ES, Whigham AS, Yarbrough WG, Weaver AM (2007) Cortactin is an essential regulator of matrix metalloproteinase secretion and extracellular matrix degradation in invadopodia. Cancer Res 67: 4227–4235. 62. Le DM, Besson A, Fogg DK, Choi KS, Waisman DM, et al. (2003) Exploitation of astrocytes by glioma cells to facilitate invasiveness: a mechanism involving matrix metalloproteinase-2 and the urokinase-type plasminogen activator- plasmin cascade. J Neurosci 23: 4034–4043. 63. Jiang YF, Goldberg ID, Shi YE (2002) Complex roles of tissue inhibitors of metalloproteinases in cancer. Oncogene 21: 2245–2252. 64. Edgar R, Domrachev M, Lash AE (2002) Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 30: 207–210. PLOS ONE | www.plosone.org 13 August 2012 | Volume 7 | Issue 8 | e43594